Responding to COVID-19: A Science-Based Approach

Brought to you by the American Public Health Association and the National Academy of Medicine, this webinar series is exploring the state of the science surrounding the current outbreak of COVID-19 in the United States and globally, with a focus on the emerging evidence on how to best mitigate its impact. Hear from trusted experts in such fields as public health, infectious disease, risk communication, and crisis standards of care.

Webinar #9: The Road to Immunity During COVID-19 — Developing and Distributing a Vaccine
June 10, 5-6:30 p.m. ET

Participants can earn 1.5 CPH, CME, CNE, or CHES continuing education credits.

Webinar #8: Summer of COVID-19 — Mitigating Direct and Indirect Impacts in the Coming Months   

As we look forward to the summer months, what can we expect to see as states and communities loosen restrictions? The webinar explored how the normal course of events, including warming weather, tornadoes and hurricanes, months of stay at-home orders and loosening of restrictions, combine to impact health and well-being.

Webinar #7: Toward the 'New Normal' — Protecting Public Health as America Reopens      

The seventh COVID-19 Conversations webinar explored how public health, economic, and workforce priorities can be balanced to ensure a safe reopening of the country; how models can inform reopening and what data is still needed; how a nationwide testing strategy can support reopening strategies; and how to ensure the public has reliable, actionable, and understandable data to guide their personal decision-making.

Webinar #6: COVID-19 and Health Equity — Exploring Disparities and Long-Term Health Impacts   

The sixth COVID-19 Conversations webinar explored the disproportionate impact COVID-19 is having on minority communities, what we can do now to combat these disturbing health inequities, and what we can learn from past pandemics about how to provide equitable care to all. 

Webinar #5: COVID-19 Testing: Possibilities, Challenges, and Ensuring Equity   

This webinar gave an update on testing for COVID-19, what data different tests will provide, how we can use that data to inform plans to ease physical distancing, and the equity issues we must all consider regarding what populations can access testing and how we can ensure equal access for all. 

Webinar #4: Crisis Standards of Care During COVID-19 

 The fourth COVID-19 Conversations webinar focused on enacting crisis standards of care during a pandemic, practical considerations for public health departments and hospital systems, and ethical considerations.    

Webinar #3: Emerging Evidence on COVID-19 Spread and Treatment

The third COVID-19 Conversations webinar examined early data on disease spread, potential treatment options, and some of the ethical implications that are even further complicated in the midst of a pandemic.    

Webinar #2: The Science of Social Distancing, Part 2

The second COVID-19 Conversations webinar: discussed benefit-risk analysis of social/physical distancing strategies, including for vulnerable populations; examined strategies for mitigating mental health impacts; and explored what science is available to guide eventual relaxation of measures. 

Webinar #1: The Science of Social Distancing, Part 1

In our first COVID-19 Conversations webinar, our lineup of public health, medical and emergency experts shared the science on social distancing as well as strategies to support it. And we explored how findings from past pandemics — as well as the current one — can shape responses today. 

More about the webinar series

The webinar series draws from and complements existing advisory activities underway at APHA and the National Academies, including the Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats, which was convened for the purpose of advising the White House and federal agencies on the U.S. response to COVID-19.

The series rapidly and regularly provides trustworthy scientific analysis of the latest COVID-19 developments for the benefit of policymakers, public health and health care officials, and the general public. The series is exploring the scientific basis for guidance issued by government, health and public health organizations, and industry, as well as answer questions that are top of mind for its audiences.

Questions? Contact us.